BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 29127596)

  • 1. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
    van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
    Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
    Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
    Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
    Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
    Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
    Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27.
    Oerlemans S; Efficace F; Shamieh O; Cardoso Borges F; de Jong C; Dong D; Lehmann J; Malak S; Petranovic D; Scholz CW; Caocci G; Molica S; Griskevicius L; Nagele E; Bredart A; Carvalho E; Xochelli A; Agelink van Rentergem J; Alrjoob W; Mueller A; Freitas AC; Cocks K; Creutzberg C; Kyriakou C; van de Poll-Franse L
    Blood Adv; 2023 Nov; 7(22):7045-7055. PubMed ID: 37738090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.
    Oerlemans S; Efficace F; Kieffer JM; Kyriakou C; Xochelli A; Levedahl K; Petranovic D; Borges FC; Bredart A; Shamieh O; Gziskevicius L; Lehmann J; Scholz CW; Caocci G; Molica S; Stamatopoulos K; Panteliadou AK; Papaioannou M; Alrjoob W; Baliakas P; Rosenquist R; Malak S; Miranda A; Cocks K; van de Poll-Franse L;
    Br J Haematol; 2022 May; 197(4):431-441. PubMed ID: 35255152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
    Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB;
    Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
    Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
    Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26.
    Holzner B; Efficace F; Basso U; Johnson CD; Aaronson NK; Arraras JI; Smith AB; Chow E; Oberguggenberger AS; Bottomley A; Steiner H; Incrocci L; Giesinger JM
    Qual Life Res; 2013 Mar; 22(2):369-78. PubMed ID: 22407356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life.
    Fitzsimmons D; Johnson CD; George S; Payne S; Sandberg AA; Bassi C; Beger HG; Birk D; Büchler MW; Dervenis C; Fernandez Cruz L; Friess H; Grahm AL; Jeekel J; Laugier R; Meyer D; Singer MW; Tihanyi T
    Eur J Cancer; 1999 Jun; 35(6):939-41. PubMed ID: 10533475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Chinese EORTC chronic lymphocytic leukaemia module - application of classical test theory and item response theory.
    Dong D; Jin J; Oerlemans S; Yu S; Yang S; Zhu J; Xu RH
    Health Qual Life Outcomes; 2020 Apr; 18(1):96. PubMed ID: 32264961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45.
    Bjelic-Radisic V; Cardoso F; Cameron D; Brain E; Kuljanic K; da Costa RA; Conroy T; Inwald EC; Serpentini S; Pinto M; Weis J; Morag O; Lindviksmoen Astrup G; Tomaszweksi KA; Pogoda K; Sinai P; Sprangers M; Aaronson N; Velikova G; Greimel E; Arraras J; Bottomley A;
    Ann Oncol; 2020 Feb; 31(2):283-288. PubMed ID: 31959345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
    Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation and Pilot Validation of the EORTC QLQ-NHL-HG29 Module in Indian Languages (Hindi and Marathi) for Use in Indian Patients with Non-Hodgkin's Lymphoma.
    Patil R; Palwe V; Pandit P; Kate S; Paleja N; Badarkhe G; Wasekar N; Bhamre R; Yasam RV; Nagarkar R
    South Asian J Cancer; 2023 Apr; 12(2):190-198. PubMed ID: 37969689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.
    Sodergren SC; Johnson CD; Gilbert A; Tomaszewski KA; Chu W; Chung HT; Dennis K; Desideri I; Glynne-Jones R; Grønlie Guren M; Kardamakis D; Nugent K; Schmidt H; Sebag-Montefiore D; Vassiliou V;
    Radiother Oncol; 2018 Feb; 126(2):222-228. PubMed ID: 29217122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
    Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
    Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
    Friend E; Yadegarfar G; Byrne C; Johnson CD; Sezer O; Pucciarelli S; Pereira SP; Chie WC; Banfield A; Ramage JK;
    Br J Cancer; 2011 Feb; 104(4):587-92. PubMed ID: 21266979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)-a report on phase III.
    Niedeggen C; Singer S; Groth M; Petermann-Meyer A; Röth A; Schrezenmeier H; Höchsmann B; Brümmendorf TH; Panse J
    Ann Hematol; 2019 Jul; 98(7):1547-1559. PubMed ID: 31115593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-cultural development of the EORTC QLQ-SWB36: a stand-alone measure of spiritual wellbeing for palliative care patients with cancer.
    Vivat B; Young T; Efficace F; Sigurđadóttir V; Arraras JI; Åsgeirsdóttir GH; Brédart A; Costantini A; Kobayashi K; Singer S;
    Palliat Med; 2013 May; 27(5):457-69. PubMed ID: 22843128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II.
    Groth M; Singer S; Niedeggen C; Petermann-Meyer A; Röth A; Schrezenmeier H; Höchsmann B; Brümmendorf TH; Panse J
    Ann Hematol; 2017 Feb; 96(2):171-181. PubMed ID: 27837250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.